- Home
- ATER vs ALLR Comparison
ATER vs ALLR Comparison
Compare ATER & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATER
- ALLR
- Stock Information
- Founded
- ATER 2014
- ALLR 2004
- Country
- ATER United States
- ALLR United States
- Employees
- ATER N/A
- ALLR N/A
- Industry
- ATER Home Furnishings
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- ATER Consumer Discretionary
- ALLR Health Care
- Exchange
- ATER Nasdaq
- ALLR Nasdaq
- Market Cap
- ATER 15.5M
- ALLR 13.3M
- IPO Year
- ATER N/A
- ALLR N/A
- Fundamental
- Price
- ATER $1.66
- ALLR $1.00
- Analyst Decision
- ATER
- ALLR
- Analyst Count
- ATER 0
- ALLR 0
- Target Price
- ATER N/A
- ALLR N/A
- AVG Volume (30 Days)
- ATER 243.8K
- ALLR 464.0K
- Earning Date
- ATER 08-07-2025
- ALLR 08-04-2025
- Dividend Yield
- ATER N/A
- ALLR N/A
- EPS Growth
- ATER N/A
- ALLR N/A
- EPS
- ATER N/A
- ALLR N/A
- Revenue
- ATER $94,191,000.00
- ALLR N/A
- Revenue This Year
- ATER N/A
- ALLR N/A
- Revenue Next Year
- ATER $7.48
- ALLR N/A
- P/E Ratio
- ATER N/A
- ALLR N/A
- Revenue Growth
- ATER N/A
- ALLR N/A
- 52 Week Low
- ATER $1.22
- ALLR $0.61
- 52 Week High
- ATER $3.84
- ALLR $7.45
- Technical
- Relative Strength Index (RSI)
- ATER 58.30
- ALLR 54.51
- Support Level
- ATER $1.34
- ALLR $0.80
- Resistance Level
- ATER $1.52
- ALLR $1.09
- Average True Range (ATR)
- ATER 0.13
- ALLR 0.07
- MACD
- ATER 0.05
- ALLR 0.02
- Stochastic Oscillator
- ATER 88.00
- ALLR 63.03
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.